S
RVMD icon

SignatureFD’s Revolution Medicines RVMD Stock Holding History

SignatureFD’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.4K Buy
950
+294
+45% +$29.7K ﹤0.01% 1392
2025
Q4 		$52.3K Buy
656
+163
+33% +$10.7K ﹤0.01% 1626
2025
Q3 		$23K Buy
493
+147
+42% +$5.76K ﹤0.01% 2050
2025
Q2 		$12.7K Buy
346
+98
+40% +$3.77K ﹤0.01% 2249
2025
Q1 		$8.77K Buy
248
+57
+30% +$2.31K ﹤0.01% 2404
2024
Q4 		$8.35K Sell
191
-2
-1% -$101 ﹤0.01% 2429
2024
Q3 		$8.75K Buy
193
+20
+12% +$871 ﹤0.01% 2380
2024
Q2 		$6.71K Buy
173
+134
+344% +$5.01K ﹤0.01% 2412
2024
Q1 		$1.26K Buy
39
+22
+129% +$652 ﹤0.01% 2913
2023
Q4 		$488 Sell
17
-106
-86% -$2.55K ﹤0.01% 2973
2023
Q3 		$3.4K Buy
123
+106
+624% +$3.14K ﹤0.01% 2618
2023
Q2 		$455 Sell
17
-47
-73% -$1.15K ﹤0.01% 3077
2023
Q1 		$1.39K Buy
64
+47
+276% +$1.16K ﹤0.01% 2911
2022
Q4 		$405 Sell
17
-17
-50% -$361 ﹤0.01% 3126
2022
Q3 		$1K Hold
34
– – ﹤0.01% 3021
2022
Q2 		$1K Sell
34
-32
-48% -$623 ﹤0.01% 2998
2022
Q1 		$2K Buy
+66
New +$1.44K ﹤0.01% 2845
2021
Q4 		– Sell
-26
Closed -$1K – 3247
2021
Q3 		$1K Buy
+26
New +$757 ﹤0.01% 2907

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SignatureFD's RVMD Position: Q1 2026 in Review

SignatureFD increased its Revolution Medicines (RVMD) stake by 45% in Q1 2026, buying an estimated $29.7K and bringing the position to 950 shares worth $92.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

SignatureFD first reported a position in RVMD in Q3 2021 and has held it in 18 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • SignatureFD held 950 shares of Revolution Medicines worth $92.4K as of Q1 2026.
  • SignatureFD bought 294 Revolution Medicines shares in Q1 2026, an estimated $29.7K.
  • Revolution Medicines made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1392 holding.
  • SignatureFD first reported a position in Revolution Medicines in Q3 2021 and has held it in 18 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.